Tag - glaucoma

Developments

Aerie Pharma receives positive CHMP opinion for Rhokiinsa in EU

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval of Aerie Pharmaceuticals’ (NASDAQ:AERI) marketing authorization application (MAA) for Rhokiinsa solution. The...

September 20, 2019

Feature

Iridex MicroPulse probes glaucoma continuum of care

By Len Zehr Iridex’s (NASDAQ:IRIX) flagship Cyclo G6 platform for the treatment of glaucoma utilizes a proprietary method of delivering laser therapy, known as MicroPulse, and disposable probes across the continuum of...

January 31, 2017

Tag - glaucoma

Aerie Pharma receives positive CHMP opinion for Rhokiinsa in EU

Iridex MicroPulse probes glaucoma continuum of care

General

More